Evolution of the 6-minute Walk Test in Patients Treated With ELEXACAFTOR / TEZACAFTOR / IVACAFTOR
Condition(s):Cystic FibrosisLast Updated:December 28, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Cystic FibrosisLast Updated:December 28, 2023Active, not recruiting
Condition(s):Myasthenia GravisLast Updated:August 12, 2020Completed
Condition(s):Cystic FibrosisLast Updated:August 6, 2021Completed
Condition(s):Multiple SclerosisLast Updated:December 21, 2020Completed
Condition(s):AgedLast Updated:April 21, 2017Completed
Condition(s):Chronic Obstructive Lung Disease; Pulmonary FibrosisLast Updated:July 31, 2012Completed
Condition(s):Acute Myocardial Infarction; Six-minute Walk TestLast Updated:August 20, 2018Unknown status
Condition(s):Lung CancerLast Updated:May 15, 2019Unknown status
Condition(s):Acute Heart FailureLast Updated:July 1, 2016Completed
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:October 3, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.